CPF Texas’s Elevance Health ELV Stock Holding History

CPF Texas’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-5,395	Closed	-$1.21M	–	238
2017 Q4	$1.21M	Buy	+5,395	New	+$1.15M	0.59%	44

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CPF Texas's ELV Position: Q1 2018 in Review

CPF Texas sold out of Elevance Health (ELV) in Q1 2018, closing a stake of 5,395 shares — an estimated $1.21M sold.

CPF Texas first reported a position in ELV in Q4 2017 and held it in 1 quarter. The position peaked at $1.21M in Q4 2017. 922 funds tracked by Wall St. Rank hold ELV as of Q1 2018.

CPF Texas reported no remaining Elevance Health position as of Q1 2018 after selling out during the quarter.
CPF Texas sold 5,395 Elevance Health shares in Q1 2018, an estimated $1.21M.
CPF Texas first reported a position in Elevance Health in Q4 2017 and held it in 1 quarter.
CPF Texas's Elevance Health position peaked at $1.21M in Q4 2017.
922 funds tracked by Wall St. Rank held Elevance Health as of Q1 2018.

Based on CPF Texas's 13F filing for Q1 2018, filed 24 May 2018.